Myriad Genetics Stock Five Year Return
MYGN Stock | USD 25.29 0.68 2.76% |
Myriad Genetics fundamentals help investors to digest information that contributes to Myriad Genetics' financial success or failures. It also enables traders to predict the movement of Myriad Stock. The fundamental analysis module provides a way to measure Myriad Genetics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Myriad Genetics stock.
Myriad |
Myriad Genetics Company Five Year Return Analysis
Myriad Genetics' Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Myriad Genetics has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Premium Stories Now
Premium StoriesFollow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
All Next | Launch Module |
Myriad Fundamentals
Return On Equity | -0.29 | ||||
Return On Asset | -0.066 | ||||
Profit Margin | (0.30) % | ||||
Operating Margin | (0.14) % | ||||
Current Valuation | 2.33 B | ||||
Shares Outstanding | 90.51 M | ||||
Shares Owned By Insiders | 2.09 % | ||||
Shares Owned By Institutions | 97.91 % | ||||
Number Of Shares Shorted | 5.95 M | ||||
Price To Earning | 31.95 X | ||||
Price To Book | 2.24 X | ||||
Price To Sales | 2.33 X | ||||
Revenue | 678.4 M | ||||
Gross Profit | 476.4 M | ||||
EBITDA | (67.8 M) | ||||
Net Income | (112 M) | ||||
Cash And Equivalents | 205.1 M | ||||
Cash Per Share | 2.54 X | ||||
Total Debt | 145 M | ||||
Debt To Equity | 0.11 % | ||||
Current Ratio | 3.07 X | ||||
Book Value Per Share | 8.40 X | ||||
Cash Flow From Operations | (106.3 M) | ||||
Short Ratio | 10.08 X | ||||
Earnings Per Share | (2.80) X | ||||
Price To Earnings To Growth | 1.40 X | ||||
Target Price | 25.27 | ||||
Number Of Employees | 2.7 K | ||||
Beta | 1.97 | ||||
Market Capitalization | 2.29 B | ||||
Total Asset | 1.2 B | ||||
Retained Earnings | (366.2 M) | ||||
Working Capital | 137.4 M | ||||
Current Asset | 314.5 M | ||||
Current Liabilities | 72.3 M | ||||
Net Asset | 1.2 B |
About Myriad Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Myriad Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Myriad Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Myriad Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Myriad Genetics Piotroski F Score and Myriad Genetics Altman Z Score analysis. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.Note that the Myriad Genetics information on this page should be used as a complementary analysis to other Myriad Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Myriad Stock analysis
When running Myriad Genetics' price analysis, check to measure Myriad Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myriad Genetics is operating at the current time. Most of Myriad Genetics' value examination focuses on studying past and present price action to predict the probability of Myriad Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Myriad Genetics' price. Additionally, you may evaluate how the addition of Myriad Genetics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is Myriad Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.